Comment on 'Clinical significance and inflammatory landscapes of a novel recurrence associated immune signature in early-stage lung adenocarcinoma'
- PMID: 32781014
- DOI: 10.1016/j.canlet.2020.07.035
Comment on 'Clinical significance and inflammatory landscapes of a novel recurrence associated immune signature in early-stage lung adenocarcinoma'
Comment in
-
Response to comment on 'Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma'.Cancer Lett. 2020 Dec 1;494:5-6. doi: 10.1016/j.canlet.2020.07.033. Epub 2020 Aug 5. Cancer Lett. 2020. PMID: 32763273 No abstract available.
Comment on
-
Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.Cancer Lett. 2020 Jun 1;479:31-41. doi: 10.1016/j.canlet.2020.03.016. Epub 2020 Mar 19. Cancer Lett. 2020. PMID: 32201203
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
